glp 1 where does it come from GLP-1 and the kidney: physiology to pharmacology and outcomes in diabetes The GLP-1 journey: from discovery

Ferroptosis detection: from approaches to applications

Retatrutide targets three receptors (GLP-1 + GIP + glucagon) and achieved 24.2% mean weight loss at 48 weeks in Phase 2

For full paper in Scientific Reports: To read more on the PET tracer development collaboration, please see EASD 2020: In vivo PET imaging of the gastric inhibitory polypeptide receptor in pancreas

We are on these medications because we want to be ALIVE and present for the people and the life we love for as long as possible

21 Headache outcomes may show more benefit over a longer trial duration, as during the relatively short time horizon of this trial other factors may also have contributed to headache such as medication overuse and opiate use, which occur in approximately one-third of IIH patients

[93] found that in patients who had HF and a preserved LVEF, a notable increase in LVEF with a 1-week treatment of liraglutide